Rimegepant Sulfate has 5 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Amiodarone, Cyclosporine, Lapatinib. Patients taking Rimegepant Sulfate should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 5
- Moderate
- 5
Moderate (5)
- Rimegepant Sulfate + Amiodarone— Potent P-gp inhibitor that may increase rimegepant exposure. Avoid another dose within 48 hours when co-administered.
- Rimegepant Sulfate + Cyclosporine— Potent P-gp inhibitor that may increase rimegepant exposure. Avoid another dose within 48 hours when co-administered.
- Rimegepant Sulfate + Lapatinib— Potent P-gp inhibitor that may increase rimegepant exposure. Avoid another dose within 48 hours when co-administered.
- Rimegepant Sulfate + Quinidine— Potent P-gp inhibitor that may increase rimegepant exposure. Avoid another dose within 48 hours when co-administered.
- Rimegepant Sulfate + Ranolazine— Potent P-gp inhibitor that may increase rimegepant exposure. Avoid another dose within 48 hours when co-administered.